ProPhase Labs, Inc.
PRPH· OTC
Released Mar 27, 2015, during market hours
10-K filed Mar 27, 2015, 86 days after period end · 0001144204-15-018860
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $8.97M | $9.60M | $9.08M | $7.46M |
| Net Income | -$676.00K | $597.00K | $453.00K | -$1.83M |
| EPS Diluted |
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR
| -$0.05 |
| $0.04 |
| $0.04 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.